Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion type Assertion NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_head.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion description "[Furthermore and extending earlier findings using tzb-resistant cells, exogenously imposed autophagy inhibition increases the anticancer effect of trastuzumab on tzb-sensitive ERBB2-expressing breast tumor cells, indicating that pharmacological autophagy suppression has a wider role in the treatment of ERBB2-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion evidence source_evidence_literature NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion SIO_000772 24492513 NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion wasDerivedFrom befree-20150227 NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.
- NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_assertion wasGeneratedBy ECO_0000203 NP379952.RAZGNXHYgRfs3Bl8vALAhLxRY9Y4nB3i0RJ47f0A7CL2U130_provenance.